series-b
Stage
2014
Founded
1
Investors
About
Veracyte develops molecular diagnostic tests that analyze the biology of tumors to assist clinicians in making personalized treatment decisions for various cancers including thyroid, prostate, breast, bladder, and lung cancer.
Explore Veracyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.